Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-08-24

Clinical Trial Update: Clinical Evaluation of Lyral® Dose Response Study [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Lyral dose response for contact dermatitis has completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lyral (null)

Snippet

Sponsor: Allerderm | Conditions: Contact Dermatitis | Phase 2 | Status: COMPLETED | Results posted: 2020-08-24